EMPLICITI (elotuzumab) — NDC 0003-2291 by E.R. Squibb & Sons, L.L.C.
EMPLICITI (elotuzumab) — NDC 0003-2291 by E.R. Squibb & Sons, L.L.C. is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: EMPLICITI; Generic name: elotuzumab; Product NDC: 0003-2291.
| Brand name | EMPLICITI |
|---|---|
| Generic name | elotuzumab |
| Product NDC | 0003-2291 |
| Labeler | E.R. Squibb & Sons, L.L.C. |
| Dosage form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active ingredients | ELOTUZUMAB 300 mg/1 |
| Pharmacologic class | Antibodies, Monoclonal [CS], SLAMF7-directed Antibody Interactions [MoA], SLAMF7-directed Immunostimulatory Antibody [EPC] |
| Marketing category | BLA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →